Cholangiocarcinoma or IgG4-associated cholangitis: How feasible it is to avoid unnecessary surgical interventions?

Annals of Surgery

Volumn 256, Issue 6, 2012, Pages 1059-1067

  Lytras, Dimitrios ^a,b   Kalaitzakis, Evangelos ^c   Webster, George J M ^c   Imber, Charles J ^b   Amin, Zahir ^c   Rodriguez Justo, Manuel ^c   Pereira, Stephen P ^c   Olde Damink, Steven W M ^a,d   Malago', Massimo ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

cholangiocarcinoma; IgG4 associated cholangitis

Indexed keywords

IMMUNOGLOBULIN G4;

ADULT; AGED; ARTICLE; BENIGN CHRONIC INFLAMMATORY BILIARY STRICTURE; BILE DUCT CARCINOMA; CHOLANGITIS; CHOLESTASIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; IGG4 ASSOCIATED CHOLANGITIS; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROLOGY;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CHOLANGITIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; UNNECESSARY PROCEDURES;

EID: 84870064516     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3182533a0a     Document Type: Article

References (48)

1. Corvera CU, Blumgart LH, Darvishian F, et al. Clinical and pathologic features of proximal biliary strictures masquerading as hilar cholangiocarcinoma. J Am Coll Surg. 2005;201:862-869.
2. Erdogan D, Kloek JJ, ten Kate FJ, et al. Immunoglobulin G4-related sclerosing cholangitis in patients resected for presumed malignant bile duct strictures. Br J Surg. 2008;95:727-734.
3. Fujita T, Kojima M, Gotohda N, et al. Incidence, clinical presentation and pathological features of benign sclerosing cholangitis of unknown origin masquerading as biliary carcinoma. J Hepatobiliary Pancreat Sci. 2010;17:139-146.
4. Gamblin TC, Krasinskas AM, Slivka AS, et al. Fibroinflammatory biliary stricture: a rare bile duct lesion masquerading as cholangiocarcinoma. J Gas-trointest Surg. 2009;13:713-721.
5. Knoefel WT, Prenzel KL, Peiper M, et al. Klatskin tumors and Klatskin mimicking lesions of the biliary tree. Eur J Surg Oncol. 2003;29:658-661.
6. Koea J, Holden A, Chau K, et al. Differential diagnosis of stenosing lesions at the hepatic hilus. World J Surg. 2004;28:466-470.
7. Lee SG, Song GW, Hwang S, et al. Surgical treatment of hilar cholangiocar-cinoma in the new era: the Asan experience. J Hepatobiliary Pancreat Sci. 2010;17:476-489.
8. Nagino M, Kamiya J, Nishio H, et al. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg. 2006;243:364-372.
9. Buc E, Lesurtel M, Belghiti J. Is preoperative histological diagnosis necessary before referral to major surgery for cholangiocarcinoma? HPB (Oxford). 2008;10:98-105.
10. Davidson BR, Gurusamy K. Is preoperative histological diagnosis necessary for cholangiocarcinoma? HPB (Oxford). 2008;10:94-97.
11. Kamisawa T, Okamoto A. IgG4-related sclerosing disease. Wo r l d J G a s t r o e n-terol. 2008;14:3948-3955.
12. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732-738.
13. Sarles H, Sarles JC, Muratore R, et al. Chronic inflammatory sclerosis of the pancreas-an autonomous pancreatic disease? Am J Dig Dis. 1961;6:688-698.
14. Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality: proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995;40:1561-1568.
15. Zen Y, Harada K, Sasaki M, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol. 2004;28:1193-1203.
16. Bjornsson E, Chari ST, Smyrk TC, et al. Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature. Hepatology. 2007;45:1547-1554.
17. Hardacre JM, Iacobuzio-Donahue CA, Sohn TA, et al. Results of pancre-aticoduodenectomy for lymphoplasmacytic sclerosing pancreatitis. Ann Surg. 2003;237:853-858; discussion 858-859.
18. Chari ST, Kloeppel G, Zhang L, et al. Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreas. 2010;39:549-554.
19. Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol. 2006;4:1010-1016; quiz 934.
20. Kamisawa T. Diagnostic criteria for autoimmune pancreatitis. J Clin Gastroen-terol. 2008;42:404-407.
21. Kwon S, Kim MH, Choi EK. The diagnostic criteria for autoimmune chronic pancreatitis: it is time to make a consensus. Pancreas. 2007;34:279-286.
22. Okazaki K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol. 2006;41:626-631.
23. Otsuki M, Chung JB, Okazaki K, et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol. 2008;43:403-408.
24. Chari ST, Takahashi N, Levy MJ, et al. A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol. 2009;7:1097-1103.
25. Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011;40:352-358.
26. Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangi-tis: clinical profile and response to therapy. Gastroenterology. 2008;134:706-715.
27. Chari ST, Longnecker DS, Kloppel G. The diagnosis of autoimmune pancreatitis: a Western perspective. Pancreas. 2009;38:846-848.
28. Siqueira E, Schoen RE, Silverman W, et al. Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. Gastrointest Endosc. 2002;56:40-47.
29. Deheragoda MG, Church NI, Rodriguez-Justo M, et al. The use of im-munoglobulin g4 immunostaining in diagnosing pancreatic and extrapan-creatic involvement in autoimmune pancreatitis. Clin Gastroenterol Hepatol. 2007;5:1229-1234.
30. Ghazale AH, Chari ST, Vege SS. Update on the diagnosis and treatment of autoimmune pancreatitis. Curr Gastroenterol Rep. 2008;10:115-121.
31. Lytras D, Olde Damink SW, Amin Z, et al. Radical surgery in the presence of biliary metallic stents: revising the palliative scenario. J Gastrointest Surg. 2011;15:489-495.
32. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-213.
33. Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187-196.
34. Gerhards MF, Vos P, van Gulik TM, et al. Incidence of benign lesions in patients resected for suspicious hilar obstruction. Br J Surg. 2001;88:48-51.
35. Sandanayake NS, Church NI, Chapman MH, et al. Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol. 2009;7:1089-1096.
36. Webster GJ, Pereira SP, Chapman RW. Autoimmune pancreatitis/IgG4- associated cholangitis and primary sclerosing cholangitis-overlapping or separate diseases? J Hepatol. 2009;51:398-402.
37. Raina A, Yadav D, Krasinskas AM, et al. Evaluation and management of autoimmune pancreatitis: experience at a large US center. Am J Gastroenterol 2009;104:2295-306.
38. Fukuda Y, Tsuyuguchi T, Sakai Y, et al. Diagnostic utility of peroral cholan-gioscopy for various bile-duct lesions. Gastrointest Endosc 2005;62:374-382.
39. Itoi T, Osanai M, Igarashi Y, et al. Diagnostic peroral video cholangioscopy is an accurate diagnostic tool for patients with bile duct lesions. Clin Gastroen-terol Hepatol. 2010;8:934-938.
40. Mendes FD, Jorgensen R, Keach J, et al. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol. 2006;101:2070-2075.
41. Kalaitzakis E, Levy M, Kamisawa T, et al. Endoscopic retrograde cholangiog-raphy does not reliably distinguish IgG4-associated cholangitis from PSC or cholangiocarcinoma. Clin Gastroenterol Hepatol. 2011;9:800-803.e2.
42. Kamisawa T, Okazaki K, Kawa S. Diagnostic criteria for autoimmune pancreatitis in Japan. World J Gastroenterol. 2008;14:4992-4994.
43. Church NI, Pereira SP, Deheragoda MG, et al. Autoimmune pancreatitis: clinical and radiological features and objective response to steroid therapy in a UK series. Am J Gastroenterol. 2007;102:2417-2425.
44. Sutton R. Autoimmune pancreatitis-also a Western disease. Gut. 2005;54:581-583.
45. Ebata T, Nagino M, Kamiya J, et al. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg. 2003;238:720-727.
46. Hemming AW, Reed AI, Fujita S, et al. Surgical management of hi-lar cholangiocarcinoma. Ann Surg. 2005;241:693-699; discussion 699-702.
47. Miyazaki M, Kimura F, Shimizu H, et al. Recent advance in the treatment of hi-lar cholangiocarcinoma: hepatectomy with vascular resection. J Hepatobiliary Pancreat Surg. 2007;14:463-468.
48. Tischendorf JJ, Hecker H, Kruger M, et al. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholan-gitis: a single center study. Am J Gastroenterol. 2007;102:107-114.